Document is current
Any future updates will be listed below
-
Authors
Cantu Gutierrez, Manuel E.
Hill, Matthew C.
Largoza, Gabrielle E.
Gillespie, William B. III https://orcid.org/0009-0009-3848-8308
Martin, James F. https://orcid.org/0000-0002-7842-9857
Wythe, Joshua D. https://orcid.org/0000-0002-3225-2937
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL159159, T32HL007284, HL159159)
American Heart Association (16GRNT31330023, 19PRE34410104)
U.S. Department of Health & Human Services | National Institutes of Health (HL136065, HL127717, HL130804, HL118761)
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 30 January 2025
First Online: 17 March 2025
Competing interests
: J.F.M. is a cofounder of and owns shares in Yap Therapeutics. The other authors declare no competing interests.
